Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies

Literature review and consensus statements.

Vitaliana De Sanctis, Paolo Bossi, Giuseppe Sanguineti, Fabio Trippa, Daris Ferrari, Almalina Bacigalupo, Carla Ida Ripamonti, Michela Buglione, S. Pergolizzi, Johannes A. Langendjik, Barbara Murphy, Judith Raber-Durlacher, Elvio G. Russi, Rajesh V. Lalla

Research output: Contribution to journalArticle

Abstract

Background: Oral mucositis (OM) due to radiotherapy and systemic therapies in head and neck cancer treatment represents a major problem causing a wide spectrum of clinical signs and symptoms. This adverse event may reduce quality of life, resulting from debilitating oral pain, bleeding, dysphagia, infections, impairment of food intake, high rate of hospitalization and may interfere with the delivery of programmed treatment plans, ultimately jeopardizing patient outcome. Globally, there is a lack of evidence on effective measures for the prevention and treatment of OM, and only scant uniform conclusions and recommendations can be derived from the existing literature and guidelines. A multidisciplinary team of Italian head and neck cancer experts met in Milan 17-18 February 2013 with the aim of reaching consensus on prophylaxis and management of mucositis. The results of the literature review and the statements that achieved consensus are reported and discussed in this paper. Material and methods: The Delphi Appropriateness Method was used as a structured communication method for achieving consensus. Subsequently, external expert reviewers evaluated the conclusions carefully according to their area of expertise. Results: This paper presents 13 clusters of statements on prophylaxis and treatment of mucositis that achieved consensus. Conclusions: OM represents a very stressfull situation for head and neck cancer patients submitted to chemo-radiation or exclusive radiation treatment. A multidisciplinary approach is mandatory, but there is still no gold-standard protocol that is prominently better than others.

Original languageEnglish
Pages (from-to)147-166
Number of pages20
JournalCritical Reviews in Oncology/Hematology
Volume100
DOIs
Publication statusPublished - Apr 1 2016

Fingerprint

Mucositis
Head and Neck Neoplasms
Consensus
Radiotherapy
Stomatitis
Therapeutics
Radiation
Deglutition Disorders
Gold
Signs and Symptoms
Hospitalization
Eating
Communication
Quality of Life
Guidelines
Hemorrhage
Pain
Infection

Keywords

  • Chemoradiation
  • Chemotherapy
  • Clinical management
  • Head and neck cancer
  • Mucositis
  • Oral mucositis
  • Radiation therapy
  • Radiotherapy
  • Supportive care

ASJC Scopus subject areas

  • Oncology
  • Hematology
  • Geriatrics and Gerontology

Cite this

Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies : Literature review and consensus statements. / De Sanctis, Vitaliana; Bossi, Paolo; Sanguineti, Giuseppe; Trippa, Fabio; Ferrari, Daris; Bacigalupo, Almalina; Ripamonti, Carla Ida; Buglione, Michela; Pergolizzi, S.; Langendjik, Johannes A.; Murphy, Barbara; Raber-Durlacher, Judith; Russi, Elvio G.; Lalla, Rajesh V.

In: Critical Reviews in Oncology/Hematology, Vol. 100, 01.04.2016, p. 147-166.

Research output: Contribution to journalArticle

De Sanctis, V, Bossi, P, Sanguineti, G, Trippa, F, Ferrari, D, Bacigalupo, A, Ripamonti, CI, Buglione, M, Pergolizzi, S, Langendjik, JA, Murphy, B, Raber-Durlacher, J, Russi, EG & Lalla, RV 2016, 'Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.', Critical Reviews in Oncology/Hematology, vol. 100, pp. 147-166. https://doi.org/10.1016/j.critrevonc.2016.01.010
De Sanctis, Vitaliana ; Bossi, Paolo ; Sanguineti, Giuseppe ; Trippa, Fabio ; Ferrari, Daris ; Bacigalupo, Almalina ; Ripamonti, Carla Ida ; Buglione, Michela ; Pergolizzi, S. ; Langendjik, Johannes A. ; Murphy, Barbara ; Raber-Durlacher, Judith ; Russi, Elvio G. ; Lalla, Rajesh V. / Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies : Literature review and consensus statements. In: Critical Reviews in Oncology/Hematology. 2016 ; Vol. 100. pp. 147-166.
@article{fe27e582d72443fbb44e5fc661d6e117,
title = "Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.",
abstract = "Background: Oral mucositis (OM) due to radiotherapy and systemic therapies in head and neck cancer treatment represents a major problem causing a wide spectrum of clinical signs and symptoms. This adverse event may reduce quality of life, resulting from debilitating oral pain, bleeding, dysphagia, infections, impairment of food intake, high rate of hospitalization and may interfere with the delivery of programmed treatment plans, ultimately jeopardizing patient outcome. Globally, there is a lack of evidence on effective measures for the prevention and treatment of OM, and only scant uniform conclusions and recommendations can be derived from the existing literature and guidelines. A multidisciplinary team of Italian head and neck cancer experts met in Milan 17-18 February 2013 with the aim of reaching consensus on prophylaxis and management of mucositis. The results of the literature review and the statements that achieved consensus are reported and discussed in this paper. Material and methods: The Delphi Appropriateness Method was used as a structured communication method for achieving consensus. Subsequently, external expert reviewers evaluated the conclusions carefully according to their area of expertise. Results: This paper presents 13 clusters of statements on prophylaxis and treatment of mucositis that achieved consensus. Conclusions: OM represents a very stressfull situation for head and neck cancer patients submitted to chemo-radiation or exclusive radiation treatment. A multidisciplinary approach is mandatory, but there is still no gold-standard protocol that is prominently better than others.",
keywords = "Chemoradiation, Chemotherapy, Clinical management, Head and neck cancer, Mucositis, Oral mucositis, Radiation therapy, Radiotherapy, Supportive care",
author = "{De Sanctis}, Vitaliana and Paolo Bossi and Giuseppe Sanguineti and Fabio Trippa and Daris Ferrari and Almalina Bacigalupo and Ripamonti, {Carla Ida} and Michela Buglione and S. Pergolizzi and Langendjik, {Johannes A.} and Barbara Murphy and Judith Raber-Durlacher and Russi, {Elvio G.} and Lalla, {Rajesh V.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.critrevonc.2016.01.010",
language = "English",
volume = "100",
pages = "147--166",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies

T2 - Literature review and consensus statements.

AU - De Sanctis, Vitaliana

AU - Bossi, Paolo

AU - Sanguineti, Giuseppe

AU - Trippa, Fabio

AU - Ferrari, Daris

AU - Bacigalupo, Almalina

AU - Ripamonti, Carla Ida

AU - Buglione, Michela

AU - Pergolizzi, S.

AU - Langendjik, Johannes A.

AU - Murphy, Barbara

AU - Raber-Durlacher, Judith

AU - Russi, Elvio G.

AU - Lalla, Rajesh V.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Background: Oral mucositis (OM) due to radiotherapy and systemic therapies in head and neck cancer treatment represents a major problem causing a wide spectrum of clinical signs and symptoms. This adverse event may reduce quality of life, resulting from debilitating oral pain, bleeding, dysphagia, infections, impairment of food intake, high rate of hospitalization and may interfere with the delivery of programmed treatment plans, ultimately jeopardizing patient outcome. Globally, there is a lack of evidence on effective measures for the prevention and treatment of OM, and only scant uniform conclusions and recommendations can be derived from the existing literature and guidelines. A multidisciplinary team of Italian head and neck cancer experts met in Milan 17-18 February 2013 with the aim of reaching consensus on prophylaxis and management of mucositis. The results of the literature review and the statements that achieved consensus are reported and discussed in this paper. Material and methods: The Delphi Appropriateness Method was used as a structured communication method for achieving consensus. Subsequently, external expert reviewers evaluated the conclusions carefully according to their area of expertise. Results: This paper presents 13 clusters of statements on prophylaxis and treatment of mucositis that achieved consensus. Conclusions: OM represents a very stressfull situation for head and neck cancer patients submitted to chemo-radiation or exclusive radiation treatment. A multidisciplinary approach is mandatory, but there is still no gold-standard protocol that is prominently better than others.

AB - Background: Oral mucositis (OM) due to radiotherapy and systemic therapies in head and neck cancer treatment represents a major problem causing a wide spectrum of clinical signs and symptoms. This adverse event may reduce quality of life, resulting from debilitating oral pain, bleeding, dysphagia, infections, impairment of food intake, high rate of hospitalization and may interfere with the delivery of programmed treatment plans, ultimately jeopardizing patient outcome. Globally, there is a lack of evidence on effective measures for the prevention and treatment of OM, and only scant uniform conclusions and recommendations can be derived from the existing literature and guidelines. A multidisciplinary team of Italian head and neck cancer experts met in Milan 17-18 February 2013 with the aim of reaching consensus on prophylaxis and management of mucositis. The results of the literature review and the statements that achieved consensus are reported and discussed in this paper. Material and methods: The Delphi Appropriateness Method was used as a structured communication method for achieving consensus. Subsequently, external expert reviewers evaluated the conclusions carefully according to their area of expertise. Results: This paper presents 13 clusters of statements on prophylaxis and treatment of mucositis that achieved consensus. Conclusions: OM represents a very stressfull situation for head and neck cancer patients submitted to chemo-radiation or exclusive radiation treatment. A multidisciplinary approach is mandatory, but there is still no gold-standard protocol that is prominently better than others.

KW - Chemoradiation

KW - Chemotherapy

KW - Clinical management

KW - Head and neck cancer

KW - Mucositis

KW - Oral mucositis

KW - Radiation therapy

KW - Radiotherapy

KW - Supportive care

UR - http://www.scopus.com/inward/record.url?scp=84960430705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960430705&partnerID=8YFLogxK

U2 - 10.1016/j.critrevonc.2016.01.010

DO - 10.1016/j.critrevonc.2016.01.010

M3 - Article

VL - 100

SP - 147

EP - 166

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -